Skip to content
Lower risk Drug recall · FDA · Published February 6, 2025

Sun Pharmaceutical Morphine Sulfate Tablets Recall: Failed Dissolution Specifications

Sun Pharmaceutical recalls 100mg Morphine Sulfate Extended-Release Tablets (100-count) due to failed dissolution specifications. This may affect medication effectiveness. Check NDC 63304-452-01 and lot number AD16615.

🇺🇸 FDA recall #D-0249-2025DrugSun Pharmaceutical ›
Take action

Contact the company

Recalling firmSUN PHARMACEUTICAL INDUSTRIES INC2 Independence Way · Princeton, NJ 08540-6620
✎ GovInfoNow plain-language explainer

Sun Pharmaceutical is recalling 100mg Morphine Sulfate Extended-Release Tablets (100-count bottles) because they failed dissolution tests. This could mean the medication doesn't work as intended, which is serious for patients needing pain relief. Read more at govinfonow.com/recall/32296-sun-pharmaceutical-morphine-sulfate-tablets-recall-failed-dissolution-specifications.

Source Summary by GovInfoNow · govinfonow.com/recall/32296-sun-pharmaceutical-morphine-sulfate-tablets-recall-failed-dissolution-specifications · Updated August 18, 2026 · FDA enforcement record: FDA #D-0249-2025

Cite this page

“Sun Pharmaceutical Morphine Sulfate Tablets Recall: Failed Dissolution Specifications.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/32296-sun-pharmaceutical-morphine-sulfate-tablets-recall-failed-dissolution-specifications. Based on FDA recall #D-0249-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0249-2025%22&limit=1).

Sun Pharmaceutical Industries Inc. recalled Morphine Sulfate Extended-Release Tablets, 100 mg, 100-count bottles due to failed dissolution specifications, the FDA said on Feb. 6, 2025.

How to tell if you have it

  • Brand: Sun Pharmaceutical
  • Product: Morphine Sulfate Extended-Release Tablets, 100 mg, 100-count bottles
  • NDC: 63304-452-01
  • Lot #: AD16615
  • Exp. Date: 07/2025

The hazard

The recall is due to failed dissolution specifications for the drug, according to the FDA.

Context

GovInfoNow's records show Sun Pharmaceutical Industries Inc. has 93 other recalls on record since May 21, 2013. Other recent recalls of similar products include Sun Pharmaceutical Nystatin Cream Recall (Sept. 14, 2026), Sun Pharmaceutical Carbamazepine Tablets Recall (Aug. 3, 2026), and Sun Pharmaceutical Perampanel 6mg Tablets Recall (June 17, 2026). Other recent recalls of similar products include Teva Metoprolol Succinate Tablets Recall (Jan. 29, 2026), Mylan Acamprosate Tablets Recall (July 24, 2026), and Teva Metoprolol Succinate Extended-Release Tablets Recall (Jan. 29, 2026).

How to tell if you have this one

Check for the NDC code 63304-452-01 and lot number AD16615 on the bottle. The product is a prescription-only medication sold by Sun Pharmaceutical in the US.

  • Brand
    Sun Pharmaceutical
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for NDC 63304-452-01 and lot number AD16615 on the bottle label.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 34 days after the firm started it.

1. Firm started the recall: Feb 6, 202512. FDA classified it Class II: Mar 3, 202523. Published in FDA’s Enforcement Report: Mar 12, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Sun Pharmaceutical recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0249-2025 (February 6, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0249-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA